Cargando…
Inhibition in the amygdala anxiety circuitry
Inhibitory neurotransmission plays a key role in anxiety disorders, as evidenced by the anxiolytic effect of the benzodiazepine class of γ-aminobutyric acid (GABA) receptor agonists and the recent discovery of anxiety-associated variants in the molecular components of inhibitory synapses. Accordingl...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938054/ https://www.ncbi.nlm.nih.gov/pubmed/29628509 http://dx.doi.org/10.1038/s12276-018-0063-8 |
_version_ | 1783320729846022144 |
---|---|
author | Babaev, Olga Piletti Chatain, Carolina Krueger-Burg, Dilja |
author_facet | Babaev, Olga Piletti Chatain, Carolina Krueger-Burg, Dilja |
author_sort | Babaev, Olga |
collection | PubMed |
description | Inhibitory neurotransmission plays a key role in anxiety disorders, as evidenced by the anxiolytic effect of the benzodiazepine class of γ-aminobutyric acid (GABA) receptor agonists and the recent discovery of anxiety-associated variants in the molecular components of inhibitory synapses. Accordingly, substantial interest has focused on understanding how inhibitory neurons and synapses contribute to the circuitry underlying adaptive and pathological anxiety behaviors. A key element of the anxiety circuitry is the amygdala, which integrates information from cortical and thalamic sensory inputs to generate fear and anxiety-related behavioral outputs. Information processing within the amygdala is heavily dependent on inhibitory control, although the specific mechanisms by which amygdala GABAergic neurons and synapses regulate anxiety-related behaviors are only beginning to be uncovered. Here, we summarize the current state of knowledge and highlight open questions regarding the role of inhibition in the amygdala anxiety circuitry. We discuss the inhibitory neuron subtypes that contribute to the processing of anxiety information in the basolateral and central amygdala, as well as the molecular determinants, such as GABA receptors and synapse organizer proteins, that shape inhibitory synaptic transmission within the anxiety circuitry. Finally, we conclude with an overview of current and future approaches for converting this knowledge into successful treatment strategies for anxiety disorders. |
format | Online Article Text |
id | pubmed-5938054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-59380542018-05-15 Inhibition in the amygdala anxiety circuitry Babaev, Olga Piletti Chatain, Carolina Krueger-Burg, Dilja Exp Mol Med Review Article Inhibitory neurotransmission plays a key role in anxiety disorders, as evidenced by the anxiolytic effect of the benzodiazepine class of γ-aminobutyric acid (GABA) receptor agonists and the recent discovery of anxiety-associated variants in the molecular components of inhibitory synapses. Accordingly, substantial interest has focused on understanding how inhibitory neurons and synapses contribute to the circuitry underlying adaptive and pathological anxiety behaviors. A key element of the anxiety circuitry is the amygdala, which integrates information from cortical and thalamic sensory inputs to generate fear and anxiety-related behavioral outputs. Information processing within the amygdala is heavily dependent on inhibitory control, although the specific mechanisms by which amygdala GABAergic neurons and synapses regulate anxiety-related behaviors are only beginning to be uncovered. Here, we summarize the current state of knowledge and highlight open questions regarding the role of inhibition in the amygdala anxiety circuitry. We discuss the inhibitory neuron subtypes that contribute to the processing of anxiety information in the basolateral and central amygdala, as well as the molecular determinants, such as GABA receptors and synapse organizer proteins, that shape inhibitory synaptic transmission within the anxiety circuitry. Finally, we conclude with an overview of current and future approaches for converting this knowledge into successful treatment strategies for anxiety disorders. Nature Publishing Group UK 2018-04-09 /pmc/articles/PMC5938054/ /pubmed/29628509 http://dx.doi.org/10.1038/s12276-018-0063-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. If you remix, transform, or build upon this article or a part thereof, you must distribute your contributions under the same license as the original. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/. |
spellingShingle | Review Article Babaev, Olga Piletti Chatain, Carolina Krueger-Burg, Dilja Inhibition in the amygdala anxiety circuitry |
title | Inhibition in the amygdala anxiety circuitry |
title_full | Inhibition in the amygdala anxiety circuitry |
title_fullStr | Inhibition in the amygdala anxiety circuitry |
title_full_unstemmed | Inhibition in the amygdala anxiety circuitry |
title_short | Inhibition in the amygdala anxiety circuitry |
title_sort | inhibition in the amygdala anxiety circuitry |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938054/ https://www.ncbi.nlm.nih.gov/pubmed/29628509 http://dx.doi.org/10.1038/s12276-018-0063-8 |
work_keys_str_mv | AT babaevolga inhibitionintheamygdalaanxietycircuitry AT pilettichataincarolina inhibitionintheamygdalaanxietycircuitry AT kruegerburgdilja inhibitionintheamygdalaanxietycircuitry |